How Agentic AI Shortens Drug Development and Boosts Patient Outcomes - Ep. 277

Hello, and welcome to the NVIDIA AI podcast. I'm your host, Noah Kravitz. AgenTek AI is reshaping the pharmaceutical landscape from streamlining clinical trials to enhancing patient engagement. Global health care intelligence company IQVIA processes data from over 1,000,000,000 non identified patient records across more than 100 countries, making our guests uniquely positioned to discuss how intelligent automation can transform health care outcomes at scale. Raja Shankar serves as vice president of machine learning at IQVIA, where he spearheads the application of artificial intelligence to transform research and development workflows in the life sciences industry. His expertise lies in developing AI solutions that accelerate clinical research and drug development processes. Avanar Broy is vice president of commercial analytics solutions at IQVIA, focusing on how AI can revolutionize pharmaceutical commercialization strategy. He brings extensive experience in leveraging advanced analytics and machine learning to optimize brand outreach and market access in health care. Gentlemen, welcome to the NVIDIA AI podcast, and thank you so much for taking the time to join. Thank you for having us. Thanks for having us. Absolutely. I really appreciate it. I know you're calling in from different time zones, had to kind of move some things to get this to work, so appreciate you guys rolling with us to get, the podcast out. Let's start with the basics, and maybe, Avanav, you can start and just tell us a little bit about what IQVIA is for listeners who might not know, and then a bit about your own role, and then, Raja, maybe you can talk about your role as well. Definitely, Noah. It's a pleasure to be here. So IQVIA is a leader in using data, tech, and analytics to accelerate innovation from clinical to commercial to drive life sciences pipeline. Right? So if you think about this, the main objective is how do we bring the drugs that are crucial for patients faster, quicker, and when they need it. Right? Right. And IQ goes the engine that is working with every life sciences company and health care organization to make that dream come true. Right? With the power of the data and analytics, which is now the the way to to approach this problem statement. In my role, I've primarily focused on the commercial business, which is basically once the drug is approved, now you have to actually take this drug and make it available for the patients. So in that, you need to understand where is your where are your patients? How do you reach them? What's the messaging? How do you make sure that every patient in every directions get those drugs at the right time for their disease test? And my job is to bring the tech and analytics together with the power of the data to make that happen. And, Raja, on your side of the house? So I'm the counterpart to Avinapp more on the r and d side. So just as he mentioned, we start, only, from a clinical …